Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Psychopharmacology|March 14, 2012
Comment on: "Effects of a novel mGlu(2/3) receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid" (Lowe S, Dean R, Ackermann B, Jackson K, Natanegara F, Anderson S, Eckstein J, Yuen E, Ayan-Oshodi M, Ho M, McKinzie D, Perry K, Svensson K, Psychopharmacology, 2012)Philip Seeman
Journal of Clinical Psychopharmacology|March 6, 2012
Comment on "A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia" by Kinon et alPhilip Seeman
International Journal of Geriatric Psychiatry|September 27, 2014
Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's diseasePhilip Seeman
Neuropharmacology|August 14, 2012
An agonist at glutamate and dopamine D2 receptors, LY404039Philip Seeman
CNS Neuroscience & Therapeutics|March 16, 2011
Schizophrenia diagnosis and treatmentPhilip Seeman
Journal of Psychiatry & Neuroscience : JPN|March 10, 2009
Glutamate and dopamine components in schizophreniaPhilip Seeman
Schizophrenia Research|January 28, 2009
Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High)Philip Seeman
Synapse (New York, N.Y.)|February 4, 2015
Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptorsPhilip Seeman
Synapse (New York, N.Y.)|July 23, 2003
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptorsPhilip Seeman, Shitij Kapur
Synapse (New York, N.Y.)|June 3, 2011
Alzheimer's disease: β-amyloid plaque formation in human brainPhilip Seeman, Neil Seeman
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Psychopharmacology|March 14, 2012
Comment on: "Effects of a novel mGlu(2/3) receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid" (Lowe S, Dean R, Ackermann B, Jackson K, Natanegara F, Anderson S, Eckstein J, Yuen E, Ayan-Oshodi M, Ho M, McKinzie D, Perry K, Svensson K, Psychopharmacology, 2012)Philip Seeman
Journal of Clinical Psychopharmacology|March 6, 2012
Comment on "A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia" by Kinon et alPhilip Seeman
International Journal of Geriatric Psychiatry|September 27, 2014
Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's diseasePhilip Seeman
Neuropharmacology|August 14, 2012
An agonist at glutamate and dopamine D2 receptors, LY404039Philip Seeman
CNS Neuroscience & Therapeutics|March 16, 2011
Schizophrenia diagnosis and treatmentPhilip Seeman
Journal of Psychiatry & Neuroscience : JPN|March 10, 2009
Glutamate and dopamine components in schizophreniaPhilip Seeman
Schizophrenia Research|January 28, 2009
Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High)Philip Seeman
Synapse (New York, N.Y.)|February 4, 2015
Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptorsPhilip Seeman
Synapse (New York, N.Y.)|July 23, 2003
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptorsPhilip Seeman, Shitij Kapur
Synapse (New York, N.Y.)|June 3, 2011
Alzheimer's disease: β-amyloid plaque formation in human brainPhilip Seeman, Neil Seeman
Pageof 11